Advertisement

Table of Contents

March 22, 2018; 131 (12)

BLOOD COMMENTARIES

SPECIAL REPORT

  • Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
    Gerrit J. Schuurhuis, Michael Heuser, Sylvie Freeman, Marie-Christine Béné, Francesco Buccisano, Jacqueline Cloos, David Grimwade, Torsten Haferlach, Robert K. Hills, Christopher S. Hourigan, Jeffrey L. Jorgensen, Wolfgang Kern, Francis Lacombe, Luca Maurillo, Claude Preudhomme, Bert A. van der Reijden, Christian Thiede, Adriano Venditti, Paresh Vyas, Brent L. Wood, Roland B. Walter, Konstanze Döhner, Gail J. Roboz and Gert J. Ossenkoppele

HOW I TREAT

CLINICAL TRIALS AND OBSERVATIONS

HEMATOPOIESIS AND STEM CELLS

LYMPHOID NEOPLASIA

THROMBOSIS AND HEMOSTASIS

  • Targeting anticoagulant protein S to improve hemostasis in hemophilia
    Raja Prince, Luca Bologna, Mirko Manetti, Daniela Melchiorre, Irene Rosa, Natacha Dewarrat, Silvia Suardi, Poorya Amini, José A. Fernández, Laurent Burnier, Claudia Quarroz, Maria Desiré Reina Caro, Yasuhiro Matsumura, Johanna A. Kremer Hovinga, John H. Griffin, Hans-Uwe Simon, Lidia Ibba-Manneschi, François Saller, Sara Calzavarini and Anne Angelillo-Scherrer

TRANSPLANTATION

  • α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease
    John M. Magenau, Steven C. Goldstein, Dan Peltier, Robert J. Soiffer, Thomas Braun, Attaphol Pawarode, Mary M. Riwes, Maggi Kennel, Joseph H. Antin, Corey S. Cutler, Vincent T. Ho, Edwin P. Alyea III, Brian L. Parkin, Gregory A. Yanik, Sung Won Choi, Eli C. Lewis, Charles A. Dinarello, John Koreth and Pavan Reddy

LETTERS TO BLOOD

BLOOD WORK